Amneal Pharmaceuticals agrees with Zentiva to divest Creo Pharma
Amneal Pharmaceuticals announced that it has entered into an agreement with Zentiva Group, under which Zentiva has acquired Creo Pharmaceuticals, a subsidiary of Amneal that operates the company’s commercial operations in the United Kingdom.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.